Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y C Cheng

Showing results (371-380 of 403) with videos related to

Pageof 41
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemiaE K Rowinsky, A Adjei, R C Donehower, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancerJ R Murren, S Anderson, J Fedele, et al.
Clinical Pharmacology and Therapeutics|March 19, 2014
Antiretroviral therapy-induced mitochondrial toxicity: potential mechanisms beyond polymerase-γ inhibitionS Selvaraj, M Ghebremichael, M Li, et al.
British Journal of Cancer|September 30, 2010
Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patientsY C Cheng, V Valero, M L Davis, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 29, 2011
A new automatic algorithm to extract craniofacial measurements from fetal three-dimensional volumesP-Y Tsai, H-C Chen, H-H Huang, et al.
Journal of Medicinal Chemistry|February 1, 1991
Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosineT S Lin, J H Yang, M C Liu, et al.
Journal of Cellular and Molecular Medicine|February 13, 2008
Faecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancerC-J Huang, C-C Chien, S-H Yang, et al.
Antimicrobial Agents and Chemotherapy|December 22, 1999
Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection modelF Le Guerhier, C Pichoud, S Guerret, et al.
Journal of Medicinal Chemistry|May 1, 1990
Antitumor agents. 111. New 4-hydroxylated and 4-halogenated anilino derivatives of 4'-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase IIK H Lee, S A Beers, M Mori, et al.
Molecular Pharmacology|January 1, 1993
A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150)J W Mellors, G J Im, E Tramontano, et al.
Pageof 41

Showing results (371-380 of 403) with videos related to

Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemiaE K Rowinsky, A Adjei, R C Donehower, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancerJ R Murren, S Anderson, J Fedele, et al.
Clinical Pharmacology and Therapeutics|March 19, 2014
Antiretroviral therapy-induced mitochondrial toxicity: potential mechanisms beyond polymerase-γ inhibitionS Selvaraj, M Ghebremichael, M Li, et al.
British Journal of Cancer|September 30, 2010
Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patientsY C Cheng, V Valero, M L Davis, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 29, 2011
A new automatic algorithm to extract craniofacial measurements from fetal three-dimensional volumesP-Y Tsai, H-C Chen, H-H Huang, et al.
Journal of Medicinal Chemistry|February 1, 1991
Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosineT S Lin, J H Yang, M C Liu, et al.
Journal of Cellular and Molecular Medicine|February 13, 2008
Faecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancerC-J Huang, C-C Chien, S-H Yang, et al.
Antimicrobial Agents and Chemotherapy|December 22, 1999
Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection modelF Le Guerhier, C Pichoud, S Guerret, et al.
Journal of Medicinal Chemistry|May 1, 1990
Antitumor agents. 111. New 4-hydroxylated and 4-halogenated anilino derivatives of 4'-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase IIK H Lee, S A Beers, M Mori, et al.
Molecular Pharmacology|January 1, 1993
A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150)J W Mellors, G J Im, E Tramontano, et al.
Pageof 41